Medexus Pharmaceuticals Inc. Common Share Purchase Warrants (MDP.WT) Fundamentals

Medexus Pharmaceuticals Inc, formerly Pediapharm Inc is a leading specialty pharmaceutical company with a strong North American commercial platform. It is focused on the therapeutic areas of auto-immune disease and pediatrics. The leading products are Rasuvo and Metoject, a unique formulation of methotrexate to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an innovative allergy medication with a unique mode of action.
SHARE INFORMATION
Market Cap$ 34,363
Shares Outstanding2,290,844
Float2,290,844
Percent Float100.0%
Short Interest1,000.00
Short Percent Float100.0%
Short Interest Ratio1.845
Short Interest Date2022-02-15
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 95,887,371
Latest Fiscal EPS$ 0.00
Latest Fiscal Date2022-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions-
Institutional Holdings Date-
Institutional Bought Previous 3 Months-
Institutional Holdings Percent0.0%
Institutional Sold Previous 3 Months-
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 1.25
52 Week Low$ 0.015
52 Week High Change$ -98.75
21 Day Moving Average$ 0.022143
21 Day Extended Moving Average$ 0.022606
50 Day Moving Average$ 0.0358
50 Day Extended Moving Average$ 0.03403
200 Day Moving Average$ 0.17585
200 Day Extended Moving Average$ 0.223275
10 Day Average Volume925
20 Day Average Volume463
30 Day Average Volume342
50 Day Average Volume1,565
Alpha0.100098
Beta-18.771803
Standard Deviation0.796975
R20.402946
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ -0.01
21 Day Percent Change-40.0%
30 Day Price Change$ -0.01
30 Day Percent Change-40.0%
Month to Date Price Change$ -0.01
Month to Date Percent Change-40.0%
Quarter to Date Price Change$ -0.005
Quarter to Date Percent Change-25.0%
180 Day Price Change$ -0.205
180 Day Percent Change-93.18%
200 Day Price Change$ -0.205
200 Day Percent Change-93.18%
Year to Date Price Change$ -0.205
Year to Date Percent Change-93.18%

Medexus Pharmaceuticals Inc. Common Share Purchase Warrants (MDP.WT) Key Ratios

PROFITABILITY
EBIT Margin11.0%
EBITDA Margin19.0%
Pre-Tax Profit Margin-44.5%
Profit Margin Count5.4%
Gross Margin49.5%
Profit Margin TOT5.4%
INCOME STATEMENTS
Revenue$ 74,485,961
Revenue Per Share$ 32.5146
Revenue (3 Years)$ 4.05
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.00
Total Debt To Equity3.08
Int Coverage0.70
Current Ratio1.00
Leverage Ratio6.60
Quick Ratio0.50
Long Term Debt To Capital0.69
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 0
Price to Sales0.000461
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book0.00
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover3.80
Invoice Turnover2.00
Assets Turnover0.40
Return Assets-2.06
Return on Equity-16.54
Return on Capital9.34

Medexus Pharmaceuticals Inc. Common Share Purchase Warrants (MDP.WT) Profile

PROFILE INFO
Issue TypeWT
SEC Type-
AuditorPricewaterhouseCoopers LLP
CEOKenneth d'Entremont.
Emplyoees24
Last AuditUE
CIK0000000000
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1 Place du Commerce
Suite 225
Verdun, QC H3E 1A2
Websitehttps://www.medexusinc.com
Facsimile+1 514 762-2336
Telephone+1 514 762-2626
Emaildstuve@burstall.com
Your Recent History
TSXV
MDP.WT
Medexus Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:ca D:20220704 22:04:19